Rx. Radar

J3230Chlorpromazine hcl injection

Published CMS Medicare Part B payment-limit context for J3230, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.

CMS payment limit

$18.143
per 50 MG · Medicare Part B
Down 13.4%from $20.958 in 2026-Q2
Current quarter
2026-Q3FinalEffective July 1, 2026
Billing unit
50 MG

Payment limit over time

$32.206$16.416

2024-Q4: $27.71; 2025-Q1: $30.479; 2025-Q2: $29.038; 2025-Q3: $27.07; 2025-Q4: $25.268; 2026-Q1: $23.767; 2026-Q2: $20.958; 2026-Q3: $18.143

No current FDA shortage matchThe latest completed FDA data has no affected record matching the Chlorpromazine Hydrochloride ingredient family (FDA data as of August 20, 2026).
Email me when FDA shortage status changes

Chlorpromazine Hcl

Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.

Put another code on your radar.

Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.